ORXOY News and Press, Orexo Ab Sp/Adr From 04/26/24

Report from Orexo AB's annual general meeting, 26 April 2024 PR Newswire UPPSALA, Sweden , April 26, 2024 /PRNewswire/ -- Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 26 April 2024 resolved, in accordance...

Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US PR Newswire UPPSALA, Sweden , April 17, 2024 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that the United States Patent and Trademark Offi...

Orexo announces that the condition for early redemption of its existing bonds has been fulfilled PR Newswire UPPSALA, Sweden , April 2, 2024 /PRNewswire/ -- On March 13 , 2024, Orexo AB (publ), (" Orexo " or the " Company ") (STO:ORX) ...

Orexo publishes the Annual and Sustainability Report for 2023 PR Newswire UPPSALA, Sweden , March 28, 2024 /PRNewswire/ -- Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com . The Swedish version o...

Correction: Notice of Annual General Meeting of Orexo PR Newswire The correction concerns the proposal regarding the number of board members as stated in the Swedish language version of the notice, which shall be five with no deputy members. UPPSALA, Sweden , ...

Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds PR Newswire UPPSALA, Sweden , March 13, 2024 /PRNewswire/ -- Orexo AB (publ), (" Orexo " or the " ...

Orexo strengthens its sustainability work by establishing a social financing framework PR Newswire UPPSALA, Sweden , March 8, 2024 /PRNewswire/ -- Orexo AB (publ), ('Orexo' or the 'Company') (STO: ORX) (OTCQX: ORXOY) today announces that the Company has...

Orexo contemplates issuance of senior secured callable floating rate social bonds and announces a conditional tender offer for its existing bonds PR Newswire UPPSALA, Sweden , March 8, 2024 /PRNewswire/ -- Orexo AB (publ), (" Orexo " or the " Company ...

Orexo and Sobi agree to advance feasibility study with AmorphOX PR Newswire Orexo and Sobi advance collaboration after successful exploratory feasibility study with the company´s world-class drug delivery platform, AmorphOX® The feasibility study confirmed that t...

2024-02-08 06:30:09 ET More on Orexo AB Historical earnings data for Orexo AB Financial information for Orexo AB Read the full article on Seeking Alpha For further details see: Orexo AB GAAP EPS of -SEK0.54, revenue of SEK166M